PFE and GILD Related Headlines
Go Back- A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
- Barclays launches U.S. biopharma coverage with four preferred picks
- Trump to announce prescription drug price agreements
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
PFE and GILD Related Press Releases
Go Back- A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
